Healthcare Committee

To be an authoritative voice on healthcare issues affecting our members and on developments in the healthcare sector. The committee provides a forum for the consideration of healthcare issues and business opportunities in the healthcare sector, by bringing together the wide range of healthcare-related professionals among the Chamber membership. The committee also offers an authoritative response to consultative and policy papers prepared by the Hong Kong Government on healthcare issues that have an effect on Chamber members; and raise such issues proactively when necessary.

Join the Committee


Hanif KanjiChairSinophi HealthcareRead moreRead lessHanif is the founder and CEO of Sinophi Healthcare, a company which invests in and manages hospitals in China, focusing on public general hospitals and selected specialty hospitals. Sinophi works in partnership with hospitals in China’s rapidly growing urban areas to deliver improvements in the delivery of healthcare. Sinophi brings to hospitals in China international hospital expertise and technology, and builds partnerships with leading UK and international healthcare service and product partners. Earlier in his career, Hanif qualified as a doctor and practiced in the UK. He then spent eleven years in investment banking in corporate finance, derivatives and asset management with financial institutions including Prudential-Bache in London and New York, and Société Générale (SocGen) in Paris and Hong Kong. Returning to healthcare in 2000, Hanif undertook (as COO for Hong Kong) the restructuring of then HK-listed ehealthcareasia.com which he turned from loss to profit in nine months. This included the development of an innovative, web-based, combined medical claims processing and clinic management software and its implementation to Hong Kong’s largest physician group of over 700 doctors. Hanif graduated in medicine from Cambridge University and received his MBA from The Wharton School, USA.
Daniel ThurleyVice ChairRocheRead moreRead lessBio pending.
Angus SlaterVice ChairBupaRead moreRead lessBio pending.
Vivienne TongChamber RepresentativeThe British Chamber of Commerce in Hong KongRead moreRead lessVivienne supports the Executive Director by managing appointments, prepares correspondences with government and leading industry bodies, arranges meetings and travel plans. Having taught in and managed learning centres and an international school before joining the Chamber, Vivienne continues her involvement in education by looking after the Chamber's Education Committee; though her degree in Public Health also means she is able to assist with the Chamber's Healthcare Committee. Additionally, Vivienne assists the Chamber team and ensures its effective and efficient operations by providing administrative and clerical services.
Alison WongMemberBird & BirdRead moreRead lessAs a partner in our Intellectual Property Group in Hong Kong and head of our Life Sciences & Healthcare Sector Group in Asia, I have 20 years' experience in advising clients in the life sciences, healthcare, food & beverage and retail & consumer sectors.

Specialising in the conduct and supervision of multi-jurisdictional IP and patent litigation, I have significant experience in litigating in the Courts in Hong Kong, China, Thailand, Philippines, Malaysia and Vietnam.

Meanwhile, my non-contentious practice covers the development and implementation of IP protection strategies, regulatory advice, IP audits and clearances.

I also advise pharmaceutical and biotechnology companies on regulatory issues, market authorisations, clinical trial agreements and public sector procurement. In recent years, I have also been involved in negotiating R&D agreements and technology licensing in both the biotechnology and pharmaceutical contexts.

Today, you'll find me ranked as a leading IP and life sciences lawyer by the major industry publications and legal directories including Chambers and Legal 500. I have also been recognised by Managing IP, ALB China IP, World IP Review, WTR 1000, IAM Patent, and China Law & Practice.

In addition to being a regular speaker at international conferences, I was involved in lobbying the HKSAR government and the HKSAR Legislative Council on copyright law reform. I am a member of APAA, INTA and the HKTMP.
Andrew ChenMemberAccenture Company Ltd.Read moreRead lessBio pending.
Cam AdamsMemberEYRead moreRead lessBio pending.
Chris ChowMemberAstraZeneca Hong Kong LtdRead moreRead lessBio pending.
Danny HoMemberUMP Healthcare Holdings LimitedRead moreRead lessDanny is British born Chinese who qualified as a Chartered Accountant in the UK in 1997 before obtaining an EMBA from Kellogg-HKUST, the World’s No.1 EMBA Program, in 2021. His work experience is as follows: - An Audit Partner with KPMG in Hong Kong and China managing prestigious clients across transport and consumer market sectors, including Cathay Pacific until his departure in 2012. - China Lead, Global Audit and Risk for Diageo Plc, the worlds largest spirits company between 2012 and 2014 - CFO, Strategic Committee and Board member of Shuijingfang (SJF) Holdings Company Limited between 2014 and 2020, a premium Baijiu brand listed on the Shanghai Stock Exchange and 66% owned by Diageo Plc. Danny took SJF from consecutive years of loss in 2014 to record profits and a 10X multiple in turnover and share price. During this time, Danny managed functions across the entire business and drove its digitalization. Within Finance, Danny setup and managed a full suite of services including SAP S4Hana implementation, Shared Service Centre, FP&A and Commercial Finance. - Group CFO and, China CFO and SVP for UMP Healthcare Holdings Limited from 2020 to present. UMP China is a start-up with a view to providing trusted primary healthcare services across the GBA in collaboration with local government while overlaying technology to enhance accessibility and affordability. UMP China occupies a unique positioning vs the competition, originating from its core as a medical services provider with 30-years experience in Hong Kong embracing technology for its China play, as opposed a tech company trying to crack healthcare.
David SwainMemberLewis SilkinRead moreRead lessDavid is the Head of Intellectual Property at Lewis Silkin's Hong Kong office. Before joining Lewis Silkin, David trained and qualified at a large city firm in London, mainly advising in relation to pharmaceutical/medical device patent litigation, before moving to Hong Kong to join one of Hong Kong's biggest local firms to concentrate on non-contentious IP issues. David has a Bachelor of Science (Hons) degree in Biochemistry from Imperial College of University of London, England, a Master of Science degree in Entrepreneurship, Science & Technology, University of Nottingham, England and an LLB from The College of Law, London, England. He also holds a Postgraduate diploma in Intellectual Property Law and Practice from Oxford University, England. He has been on secondment to GlaxoSmithKline where he advised on the sale and purchase of H1N1 vaccine to the Ministries of Health in numerous countries in the Middle East and North Africa and on numerous distribution agreements in the CIS. He is a member of the International Association for the Protection of Intellectual Property (AIPPI), the Hong Kong Institute of Trade Mark Practitioners (HKITMP), and the Licensing Executives Society (LES). At LES, he has been a Council Member of the Hong Kong Sub-Chapter since 2017, was the Chair of the Organising Committee for LES’ inaugural Asia-Pacific Young Members Congress (YMC) in Hong Kong (2018), was a Co-Chair of the Communications Committee (2019-2020), and is currently a Co-Chair of the Membership Committee and the new Chair of the YMC for 2021-2022. He is dual qualified as a Solicitor in England and Wales and Hong Kong.
Elaine WongMemberGlaxoSmithKlineRead moreRead lessBio pending.
Ernest LiMemberCentral Gastroenterology & Hepatology CenterRead moreRead lessDr. Ernest Li is the founder of Central Gastroenterology & Hepatology Center, a holistic clinic that undertakes digestive system illnesses with a multi-disciplinary approach. Management of organic digestive disease is straight forward, but functional disorders require more effort. With our in-house gastroenterologist & hepatologist, registered dietitian and clinical psychologist, CGH Center provides a well-rounded service. Dr. Ernest Li obtained his Bachelor of Science degree at McGill University, Canada, and his Bachelor of Medicine and Bachelor of Surgery degree at Chinese University of Hong Kong. He has involvements in many professional organizations such as The Hong Kong Society of Gastroenterology, The Hong Kong Association of the Study of Liver Diseases, The Hong Kong Inflammatory Bowel Disease Society and The Hong Kong Society of Gastrointestinal Motility. Committed in volunteer works, Dr. Ernest Li is the Medical Consultant of Hong Kong Fire Service Officers Association, Consultant of Board of Directors of Chung Shak-Hei (Cheung Chau) Home for the Aged, Board member of Healthy Matters Expert Advisory Board, Board member of McGill University Advisory board (Asia), President of The McGill Society of Hong Kong, ex-Chairperson of District 303 Lions Club Organ Donation Committee (2018-2021), and ex-President of Hong Kong East Lions Club 2018-2019.
Felix LeeMemberUMP Healthcare China LtdRead moreRead lessMr. Felix Lee is the President and CEO of UMP Healthcare China Limited and an Executive Director of UMP Healthcare Holdings (722:HK). Felix is dedicated to his vision of making trusted healthcare affordable and accessible for everyone. Together with other Hong Kong family doctors, Felix co-founded the GOLDTM doctors and nurses training programme in 2017, an internationally accredited programme that now provides general practice training to over 1,300 doctors and nurses, as well as having established over 150 Public-Private-Partnership clinics with various regional governments across the Greater Bay Area. Felix is also an Independent Non-executive Director of China Resources Medical (1515:HK) and Asymchem Laboratories (002821.SZ). Felix is also a Senior Vice President, head of healthcare investments at Chow Tai Fook Enterprises Limited, with responsibilities in making private equity and secondary market investments in healthcare opportunities covering application of Artificial Intelligence, health-tech and health insurance. Felix has extensive experience in healthcare reform in Mainland China, entrepreneurship, as well as in law and finance. Prior to his current roles, he was a lawyer at Freshfields Bruckhaus Deringer, an Analyst in the investment banking department UBS AG and a Director in the investment banking department of Deutsche Bank AG, Hong Kong Branch. Felix obtained a Bachelor of Laws from the London School of Economics and Political Sciences. He has been a solicitor of the High Court of Hong Kong since 2007. Felix is also a Vice Chairman of the China Committee, the Hong Kong General Chamber of Commerce.
Florence LeeMemberRoche Hong Kong LtdRead moreRead lessBio pending.
Gary TokMemberTricorRead moreRead lessBio pending.
Irene ChuMemberKPMGRead moreRead lessBio pending.
Jason BrockwellMemberAsia Medical SpecialistsRead moreRead lessJason Brockwell is an orthopaedic surgeon specialising in hip surgery. He is founder and medical director of asia medical specialists – a private specialist physician group serving Hong Kong, Macau, and China. With his experience of the local public and private medical systems and medical practice in Macau, Guangzhou, Shanghai & Beijing, he has a broad view of the issues affecting healthcare in Hong Kong and the region.
Joyce SmithMemberGleneagles Hospital Hong KongRead moreRead lessBio pending.
Kammy LeungMemberJanssenRead moreRead lessKammy has worked in the pharmaceutical and biotechnology industries for over 20 years. Early part of the career was spent on sales & marketing and business development. Her passion in bringing earlier and wider access of innovative medicines to patients has led her to steer career to policy focused functions 7 years ago. She is currently leading the Regulatory Affairs, Market Access and Health Policy teams at Janssen, Pharmaceutical Companies of Johnson and Johnson in Hong Kong. She also represents the company in various Chambers of Commerce and industry association to bring forward to the government and relevant stakeholders on concerns and issues that affect the members. Kammy is a registered pharmacist in Hong Kong and the United Kingdom.
Kara CheungMemberAmgenRead moreRead lessBio pending.
Karin MunasingheMemberN/ARead moreRead lessKarin has worked in the pharmaceutical, medical device & biotechnology industries for 20 years, of which the last 15 years were based in Asia (Shanghai, Hong Kong & Singapore). Karin has worked for MNC’s such as Eli Lilly, Fresenius Medical Care, Medtronic, Baxter & her professional experience ranges across various disciplines including Commercial Strategy, Regional (APAC) Marketing, M&A and Business Transformation. She is the co-founder of the Healthcare Drinks networking event (Hong Kong Chapter), which serves as a platform for all sectors of management in the healthcare industry to meet, exchange ideas and socialize. Her interests include mentoring healthcare start-ups & practicing yoga to maintain wellness.
Koffi KouadioMemberAsia Care GroupRead moreRead lessBio pending.
Linda BurgoyneMemberMatilda International HospitalRead moreRead lessBio pending.
Maggie PalmerMemberBritish Consulate-GeneralRead moreRead lessBio pending.
Nigel SmithMemberColliers International (Hong Kong) LtdRead moreRead lessBio pending.
Patrick DaleyMemberBryan Cave Leighton Paisner LLPRead moreRead lessBio pending.
Paul KwongMemberMott MacDonald Hong Kong LtdRead moreRead lessBio pending.
Simon BookerMemberPwCRead moreRead lessBio pending.
Tommy HanMemberPrudential Corporation AsiaRead moreRead lessTommy is Regional Government Relations Manager for Prudential Corporate Asia, leading Prudential’s policy advocacy and strategy development across 13 markets in Asia. Prior to Prudential, he held several senior roles, including China Chief Representative, at Bupa on public affairs and strategic planning. Tommy led the successful landing of Bupa’s first wholly-owned medical center in China. Prior to Bupa, Tommy was the public affairs lead for Pernod Ricard Asia and dealt with various issues related to international trade / WTO, tariff and tax, and technical regulations across over 18 markets in the region. Tommy holds a master’s degree in economics from the Maxwell School at Syracuse University, USA. He is now based in Hong Kong and lived in China, the US and Canada.
Tracy WutMemberBaker & McKenzieRead moreRead lessTracy is a partner at Baker & McKenzie's Hong Kong office and is the co-head of the Healthcare Industry Group in China and Hong Kong. She is experienced in M&A as well as corporate and commercial matters relating to investment in China, and regularly acts for clients in complex cross-border transactions. Tracy is acknowledged as a leading lawyer in her field by various legal publications including Chambers Global, Chambers Asia and IFLR1000.